Dr. David Bernstein, MD
David E. Bernstein, MD is Vice Chair of Clinical Trials in the Department of Medicine, Chief, Division of Hepatology and Director of the Center for Liver Disease for the Northwell Health System. He is a Professor of Medicine and Professor of Educational Sciences at Hofstra-Northwell Health School of Medicine.
Dr. Bernstein graduated from SUNY-Stony Brook School of Medicine in 1988. He completed his medical residency at Montefiore Medical Center and his fellowship in Gastroenterology and Hepatology at the University of Miami Affiliated Hospitals under the direction of Dr Eugene Schiff.
After completing his Fellowship, Dr. Bernstein joined the faculty of the University of Miami in the Division of Hepatology where he started his career as a clinician, teacher and researcher.
Dr. Bernstein’s main research interest has been in field of liver diseases, with most of his work concentrated on developing new treatments for chronic hepatitis C. Since 1994, he has been involved in designing programs for the treatment of hepatitis C and has been an influential national and international leader in this field. He is the author of over 100 publications, 10 book chapters, and has been the principle investigator in more than 200 clinical trials. His work has been published in such prestigious journals as the New England Journal of Medicine and The Lancet. He regularly is asked to lecture about this topic on Long Island, across the nation and around the globe. His research has led to the development of new medications which are able to cure more than 95% of patients with hepatitis C infection and in the future could lead to the eradication of hepatitis C infection in the United States.
Dr. Bernstein is active in many national and international societies and has held elective office in many of them. He is the current Immediate Past President of the Bockus International Society of Gastroenterology and a former president of the New York Gastrointestinal Society. He served for six years as the American College of Gastroenterology Governor for Long Island. He has served on numerous committees of the American Association for the Study of Liver Diseases and the American College of Gastroenterology. He is also a member of the European Society for the Study of Liver Diseases, the Asia-Pacific Association for the Study of Liver Diseases. He is a fellow of the American Association for the Study of Liver Diseases, the American College of Gastroenterology and the American College of Physicians.
Dr. Bernstein has been involved in shaping public policy and education regarding liver diseases. He serves as a special consultant to the New York State Department of Health. He is also an active lecturer at the Hofstra North Shore LIJ School of Medicine and the course director for the American College of Gastroenterology’s Hepatitis School.
Dr. Bernstein has a reputation as an outstanding clinician and maintains a busy clinical Hepatology practice. He is greatly respected by his fellow physicians and by his patients. Over the years, he has helped improve the quality of life thousands of patients and their families in the area which he serves. Castle-Connelly has recognized him as one the Best Doctors since 2006.
The American Liver Foundation, Greater New York Division is proud to honor Dr. Bernstein this year.
Corporate Partner of the Year
Habib Dable is President of U.S. Pharmaceuticals for Bayer Pharmaceuticals Inc., a role he has held since October 2015.Most recently, Habib was global head of specialty medicine for Bayer Pharmaceuticals, a role he held since 2013 and in which was responsible for overseeing four therapeutic areas for the company – hematology, oncology, ophthalmology, and neurology.
Habib began his career at Bayer in 1994 as a sales representative in Canada, where he later and moved on to various sales and marketing roles with increasing management responsibility. He then spent two years at Bayer HealthCare’s office in Osaka, Japan as Head of Strategic Planning, before moving to the United States and serving as Director of International Sales and Marketing. He was later appointed Vice President and Regional Business Unit Head responsible for Latin America, Canada, Asia Pacific and Japan.
From 2008 to 2012, Habib headed Bayer’s global therapeutic area team for Neurology / Ophthalmology, and he was Vice President for Ophthalmology and headed the global launch team for EYLEA® (aflibercept), the company’s treatment for macular degeneration.
Habib earned a Master’s of Business Administration from the University of New Brunswick in Canada, where he also completed his undergraduate study. He is married with two children, and resides in New Jersey. Habib’s personal interests include jogging, squash, golf, youth hockey and the classic English card game, whist.